BPC 157 Banned: Key Facts on the Latest FDA Decision The biggest peptide story of 2026 may not be a new study. It may be the FDA review calendar. BPC 157, TB 500, MOTS c, Semax, and other peptides are headed into FDA advisory review BPC 157: Miracle Healing Peptide or Hidden Danger? FDA's Overreach on Compounded Peptides The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Is Your Peptide Store Website FDA Aligned? onPoint Studio Web Design and Development Services